Identification of Myocardial Scarring Using Contrast‐Free Cardiac MRI in Patients With Autoimmune Rheumatic Diseases

Xiao Li,Yubo Guo,Lu Lin,Yue Wang,Peijun Liu,Qian Wang,Wei Chen,Wenji Wang,Qing Xia,Ning Huang,Aydin Eresen,Zhuoli Zhang,Zhengyu Jin,Yining Wang
DOI: https://doi.org/10.1002/jmri.29130
IF: 4.4
2023-11-12
Journal of Magnetic Resonance Imaging
Abstract:Background Late gadolinium enhancement (LGE) cardiac MRI is the method of choice in revealing the presence of myocardial scarring, but its availability remains limited in clinical practice. Purpose To assess myocardial scarring in patients with autoimmune rheumatic diseases (ARDs) using contrast‐free cardiac MRI with a radiomics model. Study Type Retrospective. Population One hundred ninety‐two patients (mean age, 41 years ± 15, 62 men) with or without ARDs, grouped into a training set of 153 patients and a testing set of 39 patients. Field Strength/Sequence 3.0 T/ cine imaging with a balanced steady‐state free precession sequence, T1 mapping with a modified Look‐Locker inversion recovery sequence, and LGE imaging with a phase‐sensitive inversion recovery gradient echo sequence. Assessment LGE assessment was the reference standard for identifying myocardial scarring. Based on motion features extracted from cine images and tissue characterization features extracted from native T1 maps, a fully automated radiomics model with T1, cine MRI, or combined inputs was developed. Statistical Tests Logistic regression model was used to detect myocardial scarring using contrast‐free cardiac MRI parameters. Receiver operating characteristic curves were analyzed to assess the accuracy, sensitivity, and specificity in detecting myocardial scarring. Sensitivities of the models were further assessed in patients with various myocardial scarring proportions. Z‐statistic and dice coefficient were assessed to compare the performance. P‐values 25% myocardial scarring. Data Conclusions The proposed radiomics model allowed for the identification of myocardial scarring similar to LGE, but on contrast‐free cardiac MRI in patients with ARDs. Evidence Level 3 Technical Efficacy Stage 1
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?